Massachusetts Institute of Technology’s first-ever vice president for equity and inclusion announced his resignation on Friday, according to an internal message from MIT President Sally Kornbluth.

Researchers developed a manufacturing technique that rapidly generates large quantities of nanoparticles coated with drug-delivering polymers, which hold great potential for treating cancer. The ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Today, The Engine, the venture firm spun out of MIT that invests in early-stage Tough Tech companies solving the world’s most urgent problems, announced the ...

MIT scientists have found a way to make gene editing far safer and more accurate — a breakthrough that could reshape how we treat hundreds of genetic diseases. By fine-tuning the tiny molecular “tools ...

A novel partnership between Massachusetts General Hospital (MGH) and Massachusetts Institute of Technology (MIT) is addressing three major challenges in clinical medicine – improving the diagnosis of ...

CAMBRIDGE, MA -- A genome-editing technique known as prime editing holds potential for treating many diseases by transforming faulty genes into functional ones. However, the process carries a small ...

Prime editing can potentially repair the vast majority of known disease-causing human mutations, but the technology, first developed in 2019, has not yet been widely used in the body, or in vivo, to ...

Last month, MIT announced that it had bestowed the title of Institute Professor, its highest faculty honor, to three longtime professors. The announcement represents the first time MIT has named new ...